Dsp Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option
NAV (R) % (D) %
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular
Direct
Nifty Pharma TRI 7.26% 22.84% 11.98% 14.12% 7.85%
SIP (XIRR) Regular
Direct
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.88 0.47 0.84 -0.62% -0.48
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.16% -19.54% -13.57% 0.82 10.52%
Fund AUM As on: 30/12/2025 3140 Cr

No data available

NAV Date:

no data

Review Date:

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 15.16
15.97
14.75 | 16.83 2 | 8 Very Good
Semi Deviation 10.52
11.32
10.52 | 12.07 1 | 8 Very Good
Max Drawdown % -13.57
-14.79
-16.36 | -12.33 2 | 8 Very Good
VaR 1 Y % -19.54
-19.09
-23.30 | -15.67 6 | 8 Average
Average Drawdown % -3.72
-5.48
-6.79 | -3.72 1 | 8 Very Good
Sharpe Ratio 0.88
1.01
0.85 | 1.20 7 | 8 Poor
Sterling Ratio 0.84
0.92
0.79 | 1.09 7 | 8 Poor
Sortino Ratio 0.47
0.53
0.43 | 0.63 7 | 8 Poor
Jensen Alpha % -0.62
0.91
-2.04 | 4.20 7 | 8 Poor
Treynor Ratio -0.48
-0.43
-0.48 | -0.40 8 | 8 Poor
Modigliani Square Measure % 21.46
23.67
20.89 | 27.07 7 | 8 Poor
Alpha % -2.91
-1.43
-3.34 | 1.08 7 | 8 Poor
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 15.16 15.97 14.75 | 16.83 2 | 8 Very Good
Semi Deviation 10.52 11.32 10.52 | 12.07 1 | 8 Very Good
Max Drawdown % -13.57 -14.79 -16.36 | -12.33 2 | 8 Very Good
VaR 1 Y % -19.54 -19.09 -23.30 | -15.67 6 | 8 Average
Average Drawdown % -3.72 -5.48 -6.79 | -3.72 1 | 8 Very Good
Sharpe Ratio 0.88 1.01 0.85 | 1.20 7 | 8 Poor
Sterling Ratio 0.84 0.92 0.79 | 1.09 7 | 8 Poor
Sortino Ratio 0.47 0.53 0.43 | 0.63 7 | 8 Poor
Jensen Alpha % -0.62 0.91 -2.04 | 4.20 7 | 8 Poor
Treynor Ratio -0.48 -0.43 -0.48 | -0.40 8 | 8 Poor
Modigliani Square Measure % 21.46 23.67 20.89 | 27.07 7 | 8 Poor
Alpha % -2.91 -1.43 -3.34 | 1.08 7 | 8 Poor
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : March 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Dsp Healthcare Fund NAV Regular Growth Dsp Healthcare Fund NAV Direct Growth
16-04-2026 37.586 41.894
15-04-2026 37.687 42.006
13-04-2026 37.079 41.325
10-04-2026 36.948 41.174
09-04-2026 36.741 40.942
08-04-2026 36.721 40.919
07-04-2026 36.151 40.282
06-04-2026 35.998 40.11
02-04-2026 35.999 40.105
01-04-2026 36.319 40.461
30-03-2026 35.974 40.073
27-03-2026 36.299 40.43
25-03-2026 36.848 41.04
24-03-2026 36.206 40.322
23-03-2026 35.844 39.918
20-03-2026 36.423 40.559
19-03-2026 36.112 40.211
18-03-2026 36.691 40.854
17-03-2026 36.546 40.691

Fund Launch Date: 12/Nov/2018
Fund Category: Pharma Fund
Investment Objective: The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.
Fund Description: An open ended equity scheme investing in healthcare and pharmaceutical sector
Fund Benchmark: S&P BSE HEALTHCARE (Total Return Index)
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.